Determination of acid α-naphthyl acetate esterase enzyme activity in peripheral blood leukocytes of gazelles (Gazella subgutturosa)

2008 ◽  
Vol 83 (6) ◽  
pp. 279-283 ◽  
Author(s):  
H Altunay ◽  
Iş Harem ◽  
MK Harem ◽  
RN Aştı ◽  
N Kurtdede
2018 ◽  
Vol 74 (10) ◽  
pp. 653-657
Author(s):  
ANTONINA SOPIŃSKA ◽  
ANNA GROCHOŁA ◽  
MONIKA ROCZEŃ-KARCZMARZ ◽  
KRZYSZTOF TOMCZUK

The aim of this study was to evaluate the effect of flumequine on the percentage of peripheral blood leukocytes of carp, alpha naphthyl acetate esterase (ANAE) activity and proliferative activity of lymphocytes stimulated with concanavalin A (Con A) and lipopolysaccharide (LPS). Flumequine was administered to 40 carp, weighing 150 ± 10 g, at a dose of 12 mg/kg, once (group I) and four times, every 2 days (group II). Among white blood cells in flumequine, treated fish (group II) observed a decrease in percentage of lymphocytes and an increase of neutrophiles. Identification of the ANAE esterase activity in fish lymphocytes of the control group showed the advantage of positive cells over the negative ones and amounted to 62.65 ± 3.22 %. After administration of flumequine in group II fish, this value decreased to 44.75 ± 3.70 %. The present study clearly demonstrated that both Con A and LPS induced lymphoid cell proliferation in vitro in group I. There was an increase in activity after stimulation of LPS and its reduction after Con A in group II. This indicates a stimulating effect of flumequine on B lymphocytes. The results of this study are not conclusive as to the positive effect of the drug on the immune system of fish and indicate the need for caution in its use. .


Author(s):  
Д.С. Орлов ◽  
Л.И. Диденко ◽  
Л.П. Назаренко

Важность неонатального скрининга болезни Гоше во многом обусловлена созданием эффективной патогенетически обоснованной терапии. Постановка диагноза строится на обнаружении снижения активности фермента бета-глюкоцереброзидазы в лейкоцитах периферической крови. Newborn screening of Gaucher diseases is important because of the development of treatment options that improve clinical outcome. The diagnosis of Gaucher disease relies on demonstration of deficient glucocerebrosidase enzyme activity in peripheral blood leukocytes.


2018 ◽  
Vol 14 (66) ◽  
pp. 075
Author(s):  
H. S. Lavryk ◽  
O. P. Korniychuk ◽  
Z. Ya. Fedorovych ◽  
Z. D. Vorobets

Sign in / Sign up

Export Citation Format

Share Document